CPC-201

· Chase Pharmaceuticals Corporation (affiliate of Allergan plc)

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CPC-201, covering 2017-08-09 to 2020-06-04. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study of CPC-201 to Treat Alzheimer's Disease Type Dementia [Phase 2]